Skip to main content
Marine Drugs logoLink to Marine Drugs
. 2020 Jan 23;18(2):71. doi: 10.3390/md18020071

Antibacterial Polyketides from Antarctica Sponge-Derived Fungus Penicillium sp. HDN151272

Mudassir Shah 1,, Chunxiao Sun 1,, Zichao Sun 1, Guojian Zhang 1,2, Qian Che 1, Qianqun Gu 1, Tianjiao Zhu 1,*, Dehai Li 1,2,3,*
PMCID: PMC7073682  PMID: 31979231

Abstract

Three new polyketides, ketidocillinones A–C (13), were discovered from the extract of an Antarctica sponge-derived fungus Penicillium sp. HDN151272. All the structures were deduced by spectroscopic data, including NMR and HRESIMS. The absolute configuration of compound 3 was established by using ECD calculation. Compounds 13 can be slowly oxidized to quinone form when exposed to air. Ketidocillinones B and C (2 and 3) exhibited potent antibacterial activity against Pseudomonas aeurigenosa, Mycobacterium phlei, and MRCNS (methicillin-resistant coagulase-negative staphylococci) with MIC values ranging from 1.56 to 25.00 µg/mL.

Keywords: Antarctica sponge-derived fungus, Penicillium sp., polyketides, antibacterial activity

1. Introduction

Microorganisms that belong to distinctive ecosystems, such as Polar Regions, have productive sources of different chemical skeletons and unusual natural products along with versatile and unparalleled biological potentials [1]. Polar regions, including the arctic, the Antarctic, and other related subregions, are considered the most inaccessible and arduous domain on the planet. To continue existence and endurance under the persistent influence of natural stressors, such as extremely low temperature, deficient of nutritional substrates, lack of metabolite transfers, UV (ultra violet-radiation) and interim concentrated heat during the Antarctic summer, the Antarctica associated microorganisms need a different range of bio-physiological adaptations which are necessary for existence [1,2]. These adaptations are frequently convoyed by manipulations to both gene regulation and metabolic pathways, in turn enlarging the opportunity to search for innovative functional metabolites with pharmaceutical potential [1,3]. The Antarctic-derived microorganisms would have the opportunity to produce novel metabolites with unusual and exclusive structures along with attractive biological activities [4,5,6,7].

During our efforts to explore new bioactive molecules from Antarctica sponge-derived microorganisms [8,9,10], a fungal strain Penicillium sp. HDN151272, isolated from an unidentified sponge sample collected in the Prydz Bay, was selected for chemical investigation due to its interesting HPLC-UV profile. A chemical investigation of the organic extract of the fungus led to the discovery of three hydroquinone polyketides (Figure 1), namely ketidocillinones A–C (13), which displayed different side chains compared with the previously reported hydroquinone polyketides [11,12]. Compounds 2 and 3 exhibited broad-spectrum antibacterial activity. Herein, we report the details of the isolation, structure elucidation, absolute configuration, and biological activities of the new compounds.

Figure 1.

Figure 1

Structures of compounds 13.

2. Results and Discussion

The fungal strain Penicillium sp. HDN151272 was cultured at 28 °C for 9 days under shaking condition. The extract (10 g) of the fermentation (30 L) was fractionated by ODS and LH-20 column chromatography and HPLC using ODS, producing compounds 1 (7.0 mg), 2 (6.0 mg), 3 (5.5 mg).

Compound 1 was isolated as a deep yellowish powder, and the HRESIMS ion detected at m/z 249.1134 [M − H] indicated a molecular formula of C14H18O4, accounting for six degrees of unsaturation. 1H NMR data (Table 1) displayed resonances for two methyls (δH 1.60, s, H3-14; 1.97, s, H3-15), three methylenes (δH 2.48, m, H2-7; 2.12, m, H2-8; 2.93, d, H2-11), three olefinic protons (δH 6.44, s, H-3; 6.44, H-6; 5.26, t, H-10), and two phenolic hydroxyls (δH 8.34, s, 1-OH; 8.30, s, 4-OH). The 13C NMR as well as DEPT and HSQC spectrum data in dicated 14 carbon resonances assignable to two sp3 methyls (δC 16.7, C-14; 16.2, C-15), three sp3 methylenes (δC 28.7, C-7; 39.9, C-8; 33.7, C-11), three sp2 methines (δC 116.2, C-3; 117.5, C-6; 116.8, C-10), and six quaternary carbons (δC 147.5, C-1; 126.0, C-2; 147.9, C-4; 121.7, C-5; 138.2, C-9; 173.5, C-12). Careful analysis of the 13C NMR data of 1 revealed a hydroquinone-type skeleton, which was further verified by the HMBC correlations (Figure 2). Detailed analysis of the COSY spectrum revealed spin systems, including H-7/H-8 and H-10/H-11 (Figure 2). The presence of side chain C-7/C-8/C-9(C-15)/C-10/C-11/C-12 was supported by the HMBC correlations from H-15 to C-8, C-9, and C-10, and from H-11 to C-9, C-10 and C-12. Further HMBC cross peaks from H-7 to C-2 and C-3 and from H-8 to C-2 attached the side chain to C-2. The E geometry of the double bond between C-9 and C-10 was inferred based on the NOESY correlations from H-15 to H-11 and from H-10 to H-8. Accordingly, the structure of 1 was established as shown and named as ketidocillinone A.

Table 1.

1H (500 MHz, J in Hz) NMR and 13C (125 MHz) NMR data for compounds 13 in DMSO-d6.

No. 1 2 3
1H 13C (Type) 1H 13C (Type) 1H 13C (Type)
1 147.5, C 147.5, C 147.5, C
2 126.0, C 125.9, C 125.4, C
3 6.44, s 116.2, CH 6.44, s 117.4, CH 6.41, s 116.2, CH
4 147.9, C 147.9, C 147.9, C
5 121.7, C 121.8, C 121.9, C
6 6.44, s 117.5, CH 6.43, s 116.3, CH 6.44, s 117.5, CH
7 2.48, m 28.7, CH2 2.46, m 28.6, CH2 2.36, ov. 27.3, CH2
8 2.12, m 39.9, CH2 2.13, t (8.5) 39.8, CH2 1.53, m 33.9, CH2
1.75, m
9 138.2, C 138.9, C 2.36, ov. 38.6, CH
10 5.26, t (7.2) 116.8, CH 5.24, m 116.1, CH 176.7, C
11 2.93, d (7.1) 33.7, CH2 3.03, d (7.1) 33.3, CH2 3.58, s 51.7, CH3
12 173.5, C 172.4, C 1.97, s 16.2, CH3
13 3.57, s 51.8, CH3 1.08, s 17.2, CH3
14 1.60, s 16.7, CH3 1.61, s 16.7, CH3
15 1.97, s ov. 16.2,CH3 1.97, s 16.2, CH3
1-OH 8.34, s 8.35, s 8.35, s
4-OH 8.30, s 8.31, s 8.33, s

Figure 2.

Figure 2

Key COSY and HMBC correlations of 1.

Compound 2 was isolated as a deep yellowish powder. The HRESIMS peak at m/z 263.1289 [M − H] indicated a molecular formula of C15H20O4, with 14 mass units more than 1. The 1D NMR data (Table 1) indicated one extra oxygenated methyl group in the structure than 1. The observed HMBC (Figure 3) correlation from H-13 to C-12 confirmed that compound 2 was a methyl ester of 1. The geometrical configuration of the double bond between C-9 and C-10 was inferred to be E based on the NOESY correlations from H-15 to H-11 and from H-10 to H-8. Thus, the structure of 2 was fully established, as shown and named as ketidocillinone B.

Figure 3.

Figure 3

Key COSY and HMBC correlations of compounds 23.

Compound 3, isolated as a light yellowish powder, was deduced to have a molecular formula of C13H18O4 by HRESIMS. Analysis of the 1H and 13C NMR (Table 1), as well as the HSQC data of 3, revealed the presence of three methyls including an oxygenated (δC 51.7, C-11), two methylenes (δC 27.3, C-7; 33.9, C-8), three methines (δC 116.2, C-3; 117.5, C-6; 38.6, C-9), and five nonprotonated sp2 carbons (δC 147.5, C-1; 125.4, C-2; 147.9, C-4; 121.9, C-5; 176.7, C-10). The almost identical UV spectra of 13 suggested they share the same aromatic chromophore, which was further confirmed by the HMBC correlations (Figure 3). The MS and 1D NMR data revealed a shortened side chain in 3, which was confirmed by COSY correlations of H-7/H-8/H-9/H-13 and HMBC correlations from H-7 to C-9, from H-8 to C-10 and C-13, from H-13 to C-8 and C-10, from H-11 to C-10 (Figure 3). Further HMBC cross peaks from H-7 to C-2 and C-3 and from H-8 to C-2 attached the side chain to C-2. Consequently, the planar structure of 3 was established as shown and named as ketidocillinone C.

The absolute configuration of C-9 in compound 3 was deduced by the calculated ECD spectra. The theoretical calculated electronic circular dichroism spectra were performed using TDDFT (time-dependent density functional theory). The optimized conformation of the model was obtained and further used for the ECD calculation at the B3LYP/6-31G (+d) level. The overall pattern of the experimental ECD spectrum was in reasonable agreement with the calculated ECD spectra (Figure 4). Thus, the absolute configuration of 3 was established as 9S.

Figure 4.

Figure 4

Calculated and experimental ECD spectra of 3 in DMSO.

Dihydroquinones can sometimes be converted to quinones by oxidative transformation. For instance, the natural p-dihydroquinones [11], and fallahydroquinone [12], isolated from the Western Australian brown alga Cystophora sp., and the southern Australian brown alga Sargassum fallax, respectively, were discovered to be the results of rapid air mediated oxidation on the (2′E)-2-(3′,7′-dimethylocta-2′,6′-dienyl)-6-methyl-2,5-cyclohexadiene-1,4-dione moiety. With regard to compounds ketidocillinones A–C, after exposure to air for about one week, these pure compounds were transformed into mixtures of both enol/keto form structures (Figure 5) with the ratios (enol:keto) 1:1 for 1 (Figure S32), 2:1 for 2 (Figure S39), and 5:4 for 3 (Figure S46), which again proved the non-enzymatic oxidation transformation from dihydroquinones to quinones in natural products. To classify the results, we also collected the NMR data of the mixture of enol/keto forms of 13 (Table 2 and Table 3, Figures S32–S51).

Figure 5.

Figure 5

Oxidative transformation of 13.

Table 2.

1H (500 MHz, J in Hz) NMR data for compounds 13 in CDCl3.

No. 1 2 3
a b a b a b
3 6.53, ov. 6.53, ov. 6.55, ov. 6.55, ov. 6.55, s 6.52, s
6 6.53, ov. 6.53, ov. 6.55, ov. 6.55, ov. 6.59, s 6.62, s
7 2.51, t (7.5) 2.62, m 2.53, t (7.4) 2.65, t (7.5) 2.42, m 2.52, ov.
8 2.20, t (7.5) 2.26, t (7.8) 2.23, t (7.4) 2.28, t (7.5) 1.88, ov. 1.89, ov.
1.62, m 1.71, m
9 2.51, ov. 2.51, ov.
10 5.32, ov. 5.28, ov. 5.32, t (6.4) 5.28,t (6.9)
11 3.02, ov. 3.02, ov. 3.04, ov. 3.04, ov. 3.68, s 3.72, s
12 2.04, s 2.17, s
13 3.67, s 3.68, s 1.19, ov. 1.20, ov.
14 2.00, s 2.12, s 2.03, s 2.16, s
15 1.64, s 1.65, s 1.66, s 1.68, s

ov. Overlapped signals.

Table 3.

13C (125 MHz) NMR data for compounds 13 in CDCl3.

No. 1 (Type) 2 (Type) 3 (Type)
a b a b a b
1 147.6, C 185.9, C 146.9, C 187.6, C 147.7, C 187.5, C
2 127.0, C 148.8, C 126.7, C 148.7, C 125.6, C 148.6, C
3 117.6, CH 132.9, CH 116.7, CH 132.8, CH 116.3, CH 132.7, CH
4 147.7, C 187.7, C 147.6, C 188.1, C 147.3, C 188.1, C
5 122.1, C 145.6, C 122.2, C 145.6, C 122.7, C 145.7, C
6 118.0, CH 133.6, CH 118.0, CH 133.5, CH 118.3, CH 133.6, CH
7 29.8, CH2 27.2, CH2 27.9, CH2 27.1, CH2 27.6, CH2 26.5, CH2
8 39.8, CH2 37.7, CH2 39.7, CH2 37.6, CH2 34.0, CH2 31.5, CH2
9 138.2, C 137.3, C 139.2, C 137.3, C 38.7, CH 39.0, CH
10 116.9, CH 118.0, CH 116.3, CH 117.2, CH 177.9, C 176.5, C
11 33.6, CH2 33.4, CH2 33.5, CH2 33.5, CH2 52.0, CH3 51.7, CH3
12 173.7, C 171.9, C 173.2, C 172.5, C 15.5, CH3 15.5, CH3
13 51.9, CH3 51.8, CH3 17.3, CH3 17.1, CH3
14 15.5, CH3 15.7, CH3 15.4, CH3 15.5, CH3
15 16.7, CH3 16.3, CH3 16.5, CH3 16.2, CH3

All the compounds were tested for antimicrobial activity. Compound 2 (a mixture of 2a and 2b) exhibited inhibitory activity against Mycobactrium phlei, Pseudomonas aeruginosa, MRCNS and Bacillus cereus with MIC ranging from 1.56 to 12.50 µg/mL, respectively, while compound 1 (mixture of 1a and 1b) was inactive (MIC > 50 µg/mL), which indicated that the methoxy group played a crucial role for the activity. Compound 3 (a mixture of 3a and 3b) also showed antibacterial activity against MRCNS, Mycobactrium phlei, Pseudomonas aeruginosa, Vibrio parahemolyticus, and Bacillus subtilis with MIC ranging from 6.25 to 25.00 µg/mL (Table 4).

Table 4.

Antibacterial activity for compounds 13 (mixtures of the phenol and quinone products) (MIC, µg/mL).

Compd. V. Parahemolyticus E. coli Prot - eus sp. B. subtilis MRCNS B. cereus P. aeruginosa M. Phlei M. albican
1 >50 >50 >50 >50 >50 >50 >50 >50 >50
2 >50 >50 >50 >50 6.25 12.50 1.56 3.13 >50
3 12.50 >50 >50 12.50 6.25 25.00 6.25 6.25 >50
Ciprofloxacin 0.52 2.07 0.52 0.98 0.98 0.98 0.98 3.91 3.91

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotations were recorded on a JASCO P-1020 (JASCO Corporation, Tokyo, Japan) digital polarimeter. UV spectra were obtained on HITACHI Chromaster 5430 (HITACHI Corporation, Tokyo, Japan), while the ECD spectra were obtained on JASCO J-815 spectropolarimeter (JASCO Corporation, Tokyo, Japan). 1H NMR, 13C NMR, DEPT, and 2D NMR spectra were recorded on an Agilent 500 MHz DD2 spectrometer (Agilent Technologies Inc., Santa Clara, CA, USA). HRESIMS spectra were obtained using a Thermo Scientific LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Column chromatography (CC) was achieved with silica gel (200–300 mesh, Qingdao Marine Chemical Inc., Qingdao, China) and Sephadex LH-20 (Amersham Biosciences, San Francisco, CA, USA). MPLC was done on a Bona-Agela CHEETAHTM HP100 (Beijing Agela Technologies Co., Ltd., Beijing, China). RP-HPLC was accomplished on an ODS column (HPLC (YMC-Pack ODS-A, 10 × 250 mm, 5 µm, 3 mL/min)) (YMC Co., Ltd., Kyoto, Japan).

3.2. Fungal Material

The fungal strain Penicillium sp. HDN151272 was isolated from a sample of an Antarctic associated marine sponge collected at Prydz Bay (depth 410 m, E 67.6°, S 66.1°, collected in mid-April 2016). The sponge was not identified due to the limited sample. Genetically, the fungal species was recognized by its morphological characteristics and ITS sequence of the rRNA gene. The sequence is available at GenBank with the accession number MN788660. The strain is deposited at the Key Laboratory of Marine Drugs, the Ministry of Education of China, Qingdao, People’s Republic of China.

3.3. Fermentation

The fungal strain Penicillium sp. HDN151272 was cultured and activated on PDA (potato dextrose agar) slants at 28 °C for 3 days. After activation of the strain, fermentation was achieved in Erlenmeyer flasks (500 mL) containing 150 mL of liquid culture medium, composed of glucose (1%), maltose (2%), mannitol (2%), monosodium glutamate (1%), KH2PO4 (0.05%), MgSO4·7H2O (0.03%), corn steep liquor (0.1%), and yeast extract (0.3%). The liquid culture medium was prepared by adding naturally collected seawater from Jiaozhou Bay, Qingdao, China, and adjusting the pH to 6.5. All the contents were subjected to autoclaving at 121 °C for 20 min. After autoclaving and cooling to 25 °C, each flask was inoculated with fungal spores and subjected to incubation at 28 °C for 9 days in shaking conditions.

3.4. Extraction and Purification

The whole fermentation broth (30 L) was filtered through a muslin cloth to separate the supernatant from the mycelia. The supernatant was extracted three times by using EtOAc (3 × 30 L), and the mycelia were homogenized and extracted three times by using MeOH (3 × 10 L). The supernatant and mycelia extracts were combined and dried in vacuo. The extract (10.0 g) was separated by VLC (vacuum liquid chromatography) on silica gel via a stepped gradient elution DCM-MeOH (100:0 to 0:100) to give twelve fractions (Fr.1 to Fr.12). Fr.5 was further separated by MPLC (C-18 ODS) using a stepped gradient elution of MeOH-H2O (5:95 to 100:0) to yield 11 subfractions (Fr.5-1 to Fr.5-11). Fr.5-5, Fr.5-6, and Fr.5-7 were further separated on a Sephadex LH-20 column with MeOH to provide five subfractions (Fr.5-5-1 to Fr.5-5-5), five fractions (Fr.5-6-1 to Fr.5-6-5), and four fractions (Fr.5-7-1 to Fr.5-7-4), respectively. Fr.5-5-3, Fr.5-6-4, and Fr.5-7-3 were separated by semi-preparative HPLC eluted with MeOH-H2O (64:36) to obtain compound 1 (7.0 mg, tR = 33.3 min), MeOH-H2O (43:57) to obtain compound 2 (6.0 mg, tR = 38.2 min), MeOH-H2O (40:60) to obtain 3 (5.5 mg, tR = 31.8 min), respectively.

Ketidocillinone A (1). deep yellowish powder; UV (MeCN) λmax (log ε): 241 (3.16) nm; IR (KBr) νmax 3276, 2929, 1698, 1653, 1203, 1139, 1026, 801, 723 cm−1; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 247.0981 [M − H] (calcd. for C14H15O4, 247.0976), m/z 249.1134 [M − H] (calcd. for C14H17O4, 247.1132).

Ketidocillinone B (2). deep yellowish powder; UV (MeCN) λmax (log ε): 241 (3.32) nm; IR (KBr) νmax 3355, 2922, 2378, 1698, 1498, 1208, 1136, 1030, 840, 802, 723 cm−1; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 261.1129 [M − H] (calcd. for C15H17O4, 261.1132), m/z 263.1289 [M − H] (calcd. for C15H19O4, 263.1289).

Ketidocillinone C (3). light yellowish powder; [α]D20 +4.56 (c 0.03, MeOH); UV (MeCN) λmax (log ε): 242 (2.56) nm; IR (KBr) νmax 3338, 2929, 2358, 1717, 1698, 1457, 1205, 1142, 1027, 874, 801, 722, 518 cm−1; ECD (2.5 mM, MeOH) λmax (Δε) 210 (+4.24), 242 (−4.56), 342 (+5.25) nm; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 235.0975 [M − H] (calcd. for C13H15O4, 235.0976), m/z 237.1131 [M − H] (calcd. for C13H17O4, 237.1132).

3.5. Assay of Antimicrobial Activity

Antimicrobial activity was determined by the broth microdilution method [13] against eight types of bacterial strains such as MRCNS, Vibrio parahemolyticus, Escherichia coli, Proteus species, Bacillus subtilis, Bacillus cereus, Mycobacterium phlei, Pseudomonas aeruginosa, and one fungus Monilia albican and were used in the antimicrobial assay. All experiments were performed in triplicates, and ciprofloxacin (J&K Chemical Technology, Beijing, China) was used as a positive control. All strains were donated by Qingdao municipal hospital and deposited at the Key Laboratory of Marine Drugs, the Ministry of Education of China, Qingdao, People’s Republic of China.

3.6. Computation Section

Conformational searches were run employing the “systematic” procedure implemented in Spartan 14 [14], using MMFF (merck molecular force field). All MMFF minima were reoptimized with DFT calculations at the B3LYP/6-31+G(d) level using the Gaussian09 program [15]. The geometry was optimized, starting from various initial conformations, with vibrational frequency calculations confirming the presence of minima. TDDFT (time-dependent DFT) calculations were performed on the six lowest-energy conformations for 3 (>5% population) for each configuration using 20 excited states and using a PCM (polarizable continuum model) for MeOH. ECD spectra were generated using the program SpecDis [16] by applying a Gaussian band shape with 0.15 eV from dipole-length rotational strengths. The dipole velocity forms yielded negligible differences. The spectra of the conformers were combined using Boltzmann weighting, with the lowest-energy conformations accounting for about 99% of the weights. The calculated spectrum was blue-shifted by 10 nm to facilitate comparison to the experimental data.

4. Conclusions

The prenylated quinones and hydroquinones are omnipresent in natural surroundings [17] and extensively isolated from marine sponges [18,19], marine algae [20,21,22], ascidians [23,24,25], and microbes [26,27]. They have been spotted to have a diverse range of bioactivities, including cytotoxic [27,28], antioxidant [21,28], and anti-inflammatory [25] activities, among which quinone and hydroquinone nucleus seemed to be the critical pharmacophore [28]. Three new hydroquinone derivatives, ketidocillinones A–C (13), were obtained from the Antarctica-sponge derived fungus Penicillium sp. HDN151272. Compounds 2 and 3 exhibited broad-spectrum antibacterial activities, especially against MRCNS and Mycobacterium phlei, which provide potential candidates for antibacterial drug development.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/18/2/71/s1. Figure S1: HPLC analysis of the crude of HDN151272; Figure S2: The 18S rDNA sequences data of Penicillium sp. HDN151272; Figure S3–S12: 1D and 2D NMR spectra of compound 1 in DMSO-d6; HRESIMS spectrum, IR spectrum, UV spectrum of compound 1; Figure S13–S21: 1D and 2D NMR data in DMSO-d6, HRESIMS spectrum, IR spectrum, UV spectrum of compound 2; Figure S23–S31: 1D and 2D NMR data of compound 3 in DMSO-d6. HRESIMS spectrum, IR spectrum, UV spectrum of compound 3; Figure S32–S38: 1D and 2D NMR spectra of compound 1 in CDCl3; Figure S39–S45: 1D and 2D NMR spectra of compound 2 in CDCl3; Figure S46–S51: 1D and 2D NMR spectra of compound 3 in CDCl3.

Author Contributions

The contributions of the respective authors are as follows: M.S. and C.S. drafted the work and performed the fermentation, extraction, isolation, and structural elucidation of the constituents. Z.S. performed the biological evaluations. G.Z., Q.C., Q.G., T.Z., and D.L. contributed to checking and confirming all procedures for the isolation and the structural elucidation. D.L. and T.Z. designed the study, supervised the laboratory work, and contributed to the critical reading of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the National Natural Science Foundation of China (41876216), the National Key R&D Program of China (grants 2018YFC1406705), NSFC-Shandong Joint Fund (U1606403), the Pilot National Laboratory for Marine Science and Technology (2018SDKJ0401-2, 2016ASKJ08-02), the National Science and Technology Major Project for Significant New Drugs Development (2018ZX09735004), the Major National Science and Technology Projects of the Ministry of Science and Technology (81991522), the Fundamental Research Funds for the Central Universities (201941001), and the Taishan Scholar Youth Expert Program in Shandong Province (tsqn201812021).

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Tian Y., Li Y.L., Zhao F.C. Secondary Metabolites from Polar Organisms. Mar. Drugs. 2017;15:28. doi: 10.3390/md15030028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bratchkova A., Ivanova V. Bioactive Metabolites Produced by Microorganisms Collected in Antarctica and the Arctic. Biotechnol. Biotech. Equip. 2014;25:1–7. [Google Scholar]
  • 3.Martinez-Rosales C., Fullana N., Musto H., Castro-Sowinski S. Antarctic DNA moving forward: Genomic plasticity and biotechnological potential. FEMS Microbiol. Lett. 2012;331:1–9. doi: 10.1111/j.1574-6968.2012.02531.x. [DOI] [PubMed] [Google Scholar]
  • 4.Wang J., Wei X., Qin X., Tian X., Liao L., Li K., Zhou X., Yang X., Wang F., Zhang T., et al. Antiviral Merosesquiterpenoids Produced by the Antarctic Fungus Aspergillus ochraceopetaliformis SCSIO 05702. J. Nat. Prod. 2016;79:59–65. doi: 10.1021/acs.jnatprod.5b00650. [DOI] [PubMed] [Google Scholar]
  • 5.Wang J., He W., Kong F., Tian X., Wang P., Zhou X., Liu Y. Ochracenes A-I, Humulane-Derived Sesquiterpenoids from the Antarctic Fungus Aspergillus ochraceopetaliformis. J. Nat. Prod. 2017;80:1725–1733. doi: 10.1021/acs.jnatprod.6b00810. [DOI] [PubMed] [Google Scholar]
  • 6.Zhou H., Li L., Wu C., Kurtan T., Mandi A., Liu Y., Gu Q., Zhu T., Guo P., Li D. Penipyridones A-F, Pyridone Alkaloids from Penicillium funiculosum. J. Nat. Prod. 2016;79:1783–1790. doi: 10.1021/acs.jnatprod.6b00218. [DOI] [PubMed] [Google Scholar]
  • 7.Liu C.C., Zhang Z.Z., Feng Y.Y., Gu Q.Q., Li D.H., Zhu T.J. Secondary metabolites from Antarctic marine-derived fungus Penicillium crustosum HDN153086. Nat. Prod. Res. 2019;33:414–419. doi: 10.1080/14786419.2018.1455045. [DOI] [PubMed] [Google Scholar]
  • 8.Zhou H., Li L., Wang W., Che Q., Li D., Gu Q., Zhu T. Chrodrimanins I and J from the Antarctic Moss-Derived Fungus Penicillium funiculosum GWT2-24. J. Nat. Prod. 2015;78:1442–1445. doi: 10.1021/acs.jnatprod.5b00103. [DOI] [PubMed] [Google Scholar]
  • 9.Li L., Li D., Luan Y., Gu Q., Zhu T. Cytotoxic metabolites from the antarctic psychrophilic fungus Oidiodendron truncatum. J. Nat. Prod. 2012;75:920–927. doi: 10.1021/np3000443. [DOI] [PubMed] [Google Scholar]
  • 10.Zhang T., Zhu M.L., Sun G.Y., Li N., Gu Q.Q., Li D.H., Che Q., Zhu T.J. Exopisiod B and farylhydrazone C, two new alkaloids from the Antarctic-derived fungus Penicillium sp. HDN14-431. J. Asian Nat. Prod. Res. 2016;18:959–965. doi: 10.1080/10286020.2016.1174699. [DOI] [PubMed] [Google Scholar]
  • 11.Capon R.J., Ghisalberti E.L., Jefferies P.R. Isoprenoid dihydroquinones from a brown alga, Cystophora sp. Phytochemistry. 1981;20:2598–2600. doi: 10.1016/0031-9422(81)83108-1. [DOI] [Google Scholar]
  • 12.Reddy P., Urban S. Meroditerpenoids from the southern Australian marine brown alga Sargassum fallax. Phytochemistry. 2009;70:250–255. doi: 10.1016/j.phytochem.2008.12.007. [DOI] [PubMed] [Google Scholar]
  • 13.Ding G., Li Y., Fu S., Liu S., Wei J., Che Y. Ambuic Acid and Torreyanic Acid Derivatives from the Endolichenic Fungus Pestalotiopsis sp. J. Nat. Prod. 2009;72:182–186. doi: 10.1021/np800733y. [DOI] [PubMed] [Google Scholar]
  • 14.Spartan’14. Wavefunction Inc.; Irvine, CA, USA: 2013. [(accessed on 22 January 2020)]. Available online: https://downloadly.ir/software/engineering-specialized/wavefuncion-spartan/ [Google Scholar]
  • 15.Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al. Gaussian 09, Revision, A.1. Gaussian Inc.; Wallingford, CT, USA: 2009. [Google Scholar]
  • 16.Bruhn T., Hemberger Y., Schauml’ffel A., Bringmann G. SpecDis, Version 1.60. University of Wuerzburg; Wuerzburg, Germany: 2011. [Google Scholar]
  • 17.Asche C. Antitumour quinones. Mini-Rev. Med. Chem. 2005;5:449–467. doi: 10.2174/1389557053765556. [DOI] [PubMed] [Google Scholar]
  • 18.Cimino G., De Stefano S.T., Minale L. Polyprenyl derivatives from the sponge Ircinia spinosula: 2-Polyprenylbenzoquinones, 2-polyprenylbenzoquinols, prenylated furans and a C-31 difuranoterpene. Tetrahedron. 1972;28:1315–1324. doi: 10.1016/S0040-4020(01)93556-2. [DOI] [Google Scholar]
  • 19.Minale L., Riccio R., Sodano G. Avarol a novel sesquiterpenoid hydroquinone with a rearranged drimane skeleton from the sponge Disidea Avara. Tetrahedron Lett. 1974;15:3401–3404. doi: 10.1016/S0040-4039(01)91918-5. [DOI] [Google Scholar]
  • 20.Laird D.W., van Altena I.A. Tetraprenyltoluquinols from the brown alga Cystophora fibrosa. Phytochemistry. 2006;67:944–955. doi: 10.1016/j.phytochem.2006.03.011. [DOI] [PubMed] [Google Scholar]
  • 21.Mori J., Iwashima M., Wakasugi H., Saito H., Matsunaga T., Ogasawara M., Takahashi S., Suzuki H., Hayashi T. New plastoquinones isolated from the brown alga, Sargassum micracanthum. Chem. Pharm. Bul. 2005;53:1159–1163. doi: 10.1248/cpb.53.1159. [DOI] [PubMed] [Google Scholar]
  • 22.Mori J., Hayashi T., Iwashima M., Matsunaga T., Saito H. Effects of plastoquinones from the brown alga Sargassum micracanthum and a new chromene derivative converted from the plastoquinones on acute gastric lesions in rats. Biol. Pharm. Bull. 2006;29:1197–1201. doi: 10.1248/bpb.29.1197. [DOI] [PubMed] [Google Scholar]
  • 23.Aknin M., Dayan T.L.-A., Rudi A., Kashman Y., Gaydou E.M. Hydroquinone antioxidants from the Indian Ocean tunicate Aplidium savignyi. J. Agric. Food Chem. 1999;47:4175–4177. doi: 10.1021/jf981103s. [DOI] [PubMed] [Google Scholar]
  • 24.Appleton D.R., Chuen C.S., Berridge M.V., Webb V.L., Copp B.R. Rossinones A and B, biologically active meroterpenoids from the Antarctic ascidian, Aplidium species. J. Org. Chem. 2009;74:9195–9198. doi: 10.1021/jo901846j. [DOI] [PubMed] [Google Scholar]
  • 25.Chan S.T., Pearce A.N., Januario A.H., Page M.J., Kaiser M., McLaughlin R.J., Harper J.L., Webb V.L., Barker D., Copp B.R. Anti-inflammatory and antimalarial meroterpenoids from the New Zealand ascidian Aplidium scabellum. J. Org. Chem. 2011;76:9151–9156. doi: 10.1021/jo201654h. [DOI] [PubMed] [Google Scholar]
  • 26.Son B.W., Kim J.C., Choi H.D., Kang J.S. A radical scavenging Farnesylhydroquinone from a marine-derived fungus Penicillium sp. Arch. Pharm. Res. 2002;25:77–79. doi: 10.1007/BF02975266. [DOI] [PubMed] [Google Scholar]
  • 27.Li X., Choi H.D., Kang J.S., Lee C.-O., Son B.W. New polyoxygenated farnesylcyclohexenones, deacetoxyyanuthone A and its hydro derivative from the marine-derived fungus Penicillium sp. J. Nat. Prod. 2003;66:1499–1500. doi: 10.1021/np030231u. [DOI] [PubMed] [Google Scholar]
  • 28.Fisch K.M., Böhm V., Wright A.D., König G.M. Antioxidative Meroterpenoids from the Brown Alga Cystoseira c rinita. J. Nat. Prod. 2003;66:968–975. doi: 10.1021/np030082f. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Marine Drugs are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES